Relay Therapeutics logo

Relay Therapeutics Share Price Today

(NASDAQ: RLAY)

Relay Therapeutics share price is $3.2 & ₹273.46 as on 26 Apr 2025, 2.30 'hrs' IST

$3.2

0.01

(0.31%)

Market is closed - opens 7 PM, 28 Apr 2025

View live Relay Therapeutics share price in Dollar and Rupees. Guide to invest in Relay Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Relay Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Relay Therapeutics share price movements

  • Today's Low: $3.06
    Today's High: $3.21

    Day's Volatility :4.52%

  • 52 Weeks Low: $1.78
    52 Weeks High: $10.72

    52 Weeks Volatility :83.44%

Relay Therapeutics (RLAY) Returns

PeriodRelay Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
-32.42%
-4.8%
0.0%
6 Months
-47.1%
-7.5%
0.0%
1 Year
-49.92%
-1.8%
0.0%
3 Years
-87.49%
2.1%
-9.5%

Relay Therapeutics (RLAY) Key Statistics

in dollars & INR

Previous Close
$3.19
Open
$3.14
Today's High
$3.205
Today's Low
$3.06
Market Capitalization
$527.2M
Today's Volume
$1.9M
52 Week High
$10.72
52 Week Low
$1.775
Revenue TTM
$10.0M
EBITDA
$-380.2M
Earnings Per Share (EPS)
$-2.51
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-44.15%

How to invest in Relay Therapeutics Stock (RLAY) from India?

It is very easy for Indian residents to invest directly in Relay Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Relay Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Relay Therapeutics or RLAY on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Relay Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Relay Therapeutics shares which would translate to 0.267 fractional shares of Relay Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Relay Therapeutics, in just a few clicks!

Returns in Relay Therapeutics (RLAY) for Indian investors in Rupees

The Relay Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Relay Therapeutics investment value today

Current value as on today

₹52,811

Returns

₹47,189

(-47.19%)

Returns from Relay Therapeutics Stock

₹49,765 (-49.76%)

Dollar Returns

₹2,575 (+2.58%)

Indian investors sentiment towards Relay Therapeutics (RLAY)

42%

Period: Mar 26, 2025 to Apr 25, 2025. Change in 30 Days versus previous period

Search interest for Relay Therapeutics Stock from India on INDmoney has increased by 42% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Relay Therapeutics

  • SB INVESTMENT ADVISERS (UK) LTD

    16.46%

  • Vanguard Group Inc

    8.87%

  • BlackRock Inc

    8.66%

  • Casdin Capital, LLC

    5.28%

  • TANG CAPITAL MANAGEMENT LLC

    4.76%

  • Bellevue Group AG

    4.35%

Analyst Recommendation on Relay Therapeutics

Rating
Trend

Buy

    83%Buy

    16%Hold

    0%Sell

Based on 18 Wall street analysts offering stock ratings for Relay Therapeutics(by analysts ranked 0 to 5 stars)

Analyst Forecast on Relay Therapeutics Stock (RLAY)

What analysts predicted

Upside of 442.61%

Target:

$17.36

Current:

$3.20

Insights on Relay Therapeutics Stock (Ticker Symbol: RLAY)

  • Price Movement

    In the last 7 days, RLAY stock has moved up by 18.6%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, -1.0K → 10.00M (in $), with an average increase of 100.0% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -92.21M → -76.00M (in $), with an average increase of 10.3% per quarter
  • RLAY vs ONC (1 yr)

    In the last 1 year, Beone Medicines Ltd has given 72.4% return, outperforming this stock by 120.6%
  • RLAY vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 57.3% return, outperforming this stock by 146.5%
  • Price to Sales

    ForRLAY every $1 of sales, investors are willing to pay $45.7, whereas for Beone Medicines Ltd, the investors are paying $6.8 for every $1 of sales.

Relay Therapeutics Technicals Summary

Sell

Neutral

Buy

Relay Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Relay Therapeutics (RLAY) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Relay Therapeutics Inc logo
6.69%
-47.1%
-49.92%
-87.49%
-90.9%
Regeneron Pharmaceuticals, Inc. logo
-5.67%
-35.41%
-32.09%
-10.95%
9.54%
Beone Medicines Ltd logo
-2.45%
17.93%
66.79%
62.33%
55.25%
Vertex Pharmaceuticals Incorporated logo
-2.01%
3.38%
23.9%
84.27%
83.41%
Alnylam Pharmaceuticals, Inc. logo
-10.48%
-15.44%
69.29%
56.6%
70.01%

About Relay Therapeutics

Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It transforms the drug discovery process with a focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-2608, a pan-mutant and isoform-selective phosphoinostide 3 kinase alpha, or PI3Ka, inhibitor that is in clinical development for the treatment of breast cancer, solid tumor, and vascular malformations; and aGal chaperone for Fabry diseases. It also develops RLY-8161, an oncogene driver that belongs to the RAS family of signaling proteins; and RLY-1013, a degrader of estrogen receptor alpha. In addition, the company develops lirafugratinib (RLY-4008), a receptor tyrosine kinase for the treatment of cancer. It has collaboration and license agreements with D. E. Shaw Research, LLC to research certain biological targets through the use of D. E. Shaw Research computational modeling capabilities focused on analysis of protein motion to develop and commercialize compounds and products directed to such targets; Elevar Therapeutics, Inc. for the development and commercialization of RLY-4008; and Pfizer Inc. for the development of RLY-2608 in combination with fulvestrant and atirmociclib. The company was formerly known as Allostery, Inc. and changed its name to Relay Therapeutics, Inc. in December 2015. Relay Therapeutics, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Organization
Relay Therapeutics
Employees
261
CEO
Mr. Thomas Catinazzo
Industry
Health Technology

Management People of Relay Therapeutics

NameTitle
Mr. Thomas Catinazzo
Chief Financial Officer
Mr. Brian R. Adams J.D.
Chief Legal Officer & Secretary
Dr. Donald A. Bergstrom M.D., Ph.D.
President of Research & Development
Ms. Dorothee Kern Ph.D.
Founder
Dr. David Elliot Shaw Ph.D.
Founder
Mr. Matthew P. Jacobson Ph.D.
Founder
Mr. Jim Watters Ph.D.
Chief Scientific Officer
Ms. Jeanne Gray
Chief People Officer
Dr. Beni B. Wolf M.D., Ph.D.
Chief Medical Officer & Head of Precision Medicine
Dr. Mahesh Padval Ph.D.
Chief Pharmaceutical Development Officer

Important FAQs about investing in RLAY Stock from India :

What is Relay Therapeutics share price today?

Relay Therapeutics share price today stands at $3.20, Open: $3.14 ; Previous Close: $3.19 ; High: $3.21 ; Low: $3.06 ; 52 Week High: $10.72 ; 52 Week Low: $1.78.

The stock opens at $3.14, after a previous close of $3.19. The stock reached a daily high of $3.21 and a low of $3.06, with a 52-week high of $10.72 and a 52-week low of $1.78.

Can Indians buy Relay Therapeutics shares?

Yes, Indians can invest in the Relay Therapeutics (RLAY) from India.

With INDmoney, you can buy Relay Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Relay Therapeutics at zero transaction cost.

How can I buy Relay Therapeutics shares from India?

It is very easy to buy Relay Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Relay Therapeutics (RLAY) be purchased?

Yes, you can buy fractional shares of Relay Therapeutics with INDmoney app.

What are the documents required to start investing in Relay Therapeutics stocks?

To start investing in Relay Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Relay Therapeutics Stock (RLAY)?

Today’s highest price of Relay Therapeutics (RLAY) is $3.21.

Today’s lowest price of Relay Therapeutics (RLAY) is $3.06.

What is today's market capitalisation of Relay Therapeutics?

Today's market capitalisation of Relay Therapeutics RLAY is 527.2M

What is the 52 Week High and Low Range of Relay Therapeutics Stock (RLAY)?

  • 52 Week High

    $10.72

  • 52 Week Low

    $1.78

What are the historical returns of Relay Therapeutics (RLAY)?

  • 1 Month Returns

    6.69%

  • 3 Months Returns

    -47.1%

  • 1 Year Returns

    -49.92%

  • 5 Years Returns

    -90.9%

Who is the Chief Executive Officer (CEO) of Relay Therapeutics ?

Mr. Thomas Catinazzo is the current Chief Executive Officer (CEO) of Relay Therapeutics.